Eyestil Synfo 10ml

SIFI S.p.A. is a leading international ophthalmic company headquartered in Catania, Italy, with a history in eye care dating back to 1935. The company operates an integrated business model that spans research and development (R&D), manufacturing, and the commercialization of pharmaceutical specialties and surgical medical devices. In September 2025, SIFI was fully acquired by the Spanish pharmaceutical group Faes Farma for an initial value of €270 million, serving as the group's dedicated ophthalmic franchise. Core Business and Product Categories SIFI develops a wide range of therapeutic solutions for the prevention and treatment of various ocular pathologies. Its portfolio includes: Nutraceuticals and Supplements: Products like Vitreoclar (for vitreous floaters and degenerations), Ocuplus, and Ocuplus Mega (for retinal health and AMD). Hygiene and Surface Care: Klimi Med ophthalmic wipes for periocular hygiene. Pharmaceutical Gels and Drops: Xanternet (re-epithelizing gel for corneal lesions) and Eyestil Synfo (lubricating eye drops for dry eye). Surgical Devices: Innovative intraocular lenses (IOLs), such as the WELL Fusion® system and EVOLUX®, designed for cataract and refractive surgeries. Specialty Drugs: Akantior, a breakthrough therapy for treating Acanthamoeba Keratitis, a rare corneal infection. Global Operations and Reach Presence: SIFI operates directly in Italy, Spain, France, Romania, Mexico, and Turkey. Export: Its products are exported to more than 60 countries worldwide. Manufacturing: The company maintains state-of-the-art facilities in Italy. The pharmaceutical plant uses Blow-Fill-Seal (BFS) technology for aseptic production of eye drops and gels, while its surgical plant specializes in high-precision IOL manufacturing.